![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
MARA Holdings
MARA
Microsoft
MSFT
Coinbase
COIN
Tesla
TSLA
Salesforce
CRM
US Stock MarketDetailed Quotes
CHRS Coherus BioSciences
- 1.595
- -0.055-3.33%
Trading Dec 12 11:00 ET
183.77MMarket Cap-17.72P/E (TTM)
1.668High1.580Low538.40KVolume1.640Open1.650Pre Close868.14KTurnover0.52%Turnover RatioLossP/E (Static)115.21MShares3.70052wk High-2.09P/B164.77MFloat Cap0.66052wk Low--Dividend TTM103.30MShs Float38.100Historical High--Div YieldTTM5.33%Amplitude0.660Historical Low1.612Avg Price1Lot Size
Coherus BioSciences Stock Forum
Sign in to post a comment
Note: The presence of 30 stock picks reflects the reality that not all stocks respond to their press releases immediately. For instance, today’s market activity saw certain high-performing stocks overshadow promising PRs, suggesting that it may take a day, several days, or even a week for the market to fully digest and react. I encourage you to save the watchlist I p...
34
7
6
$Coherus BioSciences (CHRS.US)$ sucks, not looking good anymore
1
$Coherus BioSciences (CHRS.US)$ bullish finally
2
$Coherus BioSciences (CHRS.US)$ once the shorters got squeeze, easily $4. All in now before its too late.
1
$Coherus BioSciences (CHRS.US)$
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
7 minutes ago, 4:00 AM PST
Via GlobeNewswire
CHRS
Share
- Coherus to focus exclusively on innovative immuno-oncology programs that include LOQTORZI®, an FDA approved, next-generation programmed cell death protein 1 (PD-1) inhibitor -
- Proceeds to fund development of key combination programs with LOQTORZI, including casdozokitug, a first-in-class, cli...
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
7 minutes ago, 4:00 AM PST
Via GlobeNewswire
CHRS
Share
- Coherus to focus exclusively on innovative immuno-oncology programs that include LOQTORZI®, an FDA approved, next-generation programmed cell death protein 1 (PD-1) inhibitor -
- Proceeds to fund development of key combination programs with LOQTORZI, including casdozokitug, a first-in-class, cli...
1
No comment yet
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
AhmadFH : Thanks Jag
71580478 : love it, thanks! what do you think about SHIM?
JMK47 : thanks for all your effort
101628821 : Is it going to melt or continue to rise today?
101821671 : Do you have any opinions on the stock symbol SOAR?
View more comments...